Novavax, Inc.
NASDAQ:NVAX
13.61 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 983.705 | 1,598.951 | 1,146.29 | 475.598 | 18.662 | 34.288 | 31.176 | 15.353 | 36.25 | 30.659 | 20.915 | 22.076 | 14.688 | 0.343 | 0.325 | 1.064 | 1.513 | 4.683 | 7.388 | 8.26 | 11.785 | 15.005 | 24.066 | 2.475 | 1.2 | 0.7 | 0.5 | 0.1 |
| Cost of Revenue
| 279.468 | 902.639 | 12.661 | 747.027 | 113.842 | 0 | 0 | 237.939 | 162.644 | 14.987 | 8.222 | 14.692 | 7.003 | 0 | 0 | 0 | 0.221 | 6.473 | 5.791 | 3.49 | 2.057 | 3.559 | 4.052 | -0.594 | -0.4 | -0.3 | -0.3 | -0.3 |
| Gross Profit
| 704.237 | 696.312 | 1,133.629 | -271.429 | -95.18 | 34.288 | 31.176 | -222.586 | -126.394 | 15.672 | 12.693 | 7.384 | 7.685 | 0.343 | 0.325 | 1.064 | 1.292 | -1.79 | 1.597 | 4.77 | 9.728 | 11.446 | 20.014 | 3.069 | 1.6 | 1 | 0.8 | 0.4 |
| Gross Profit Ratio
| 0.716 | 0.435 | 0.989 | -0.571 | -5.1 | 1 | 1 | -14.498 | -3.487 | 0.511 | 0.607 | 0.334 | 0.523 | 1 | 1 | 1 | 0.854 | -0.382 | 0.216 | 0.577 | 0.825 | 0.763 | 0.832 | 1.24 | 1.333 | 1.429 | 1.6 | 4 |
| Reseach & Development Expenses
| 656.002 | 1,235.278 | 2,534.508 | 747.027 | 113.842 | 173.797 | 168.435 | 237.939 | 162.644 | 79.435 | 50.308 | 26.061 | 17.885 | 28.032 | 25.78 | 24.334 | 17.6 | 11.529 | 5.075 | 7.369 | 10.058 | 11.501 | 10.775 | 9.358 | 3.4 | 3.4 | 2.9 | 3.7 |
| General & Administrative Expenses
| 0 | 488.691 | 298.358 | 145.29 | 34.417 | 34.409 | 34.451 | 46.527 | 30.842 | 19.928 | 14.819 | 10.988 | 11.379 | 10.805 | 11.928 | 11.09 | 13.963 | 11.288 | 16.658 | 33.027 | 15.724 | 21.503 | 18.494 | 5.859 | 2.4 | 2.5 | 2.4 | 1.9 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.101 | 6.92 | 23.588 | 7.79 | 12.848 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 457.162 | 488.691 | 298.358 | 145.29 | 34.417 | 34.409 | 34.451 | 46.527 | 30.842 | 19.928 | 14.819 | 10.988 | 11.379 | 10.805 | 11.928 | 11.09 | 13.963 | 11.288 | 16.658 | 33.027 | 15.724 | 21.503 | 18.494 | 5.859 | 2.4 | 2.5 | 2.4 | 1.9 |
| Other Expenses
| -6.1 | -382.921 | -8.197 | 12.591 | -0.013 | 0.108 | 0.067 | -0.031 | -0.12 | 74.989 | 0.182 | 0.045 | 0 | 0 | 0 | 0 | 16.212 | 11.192 | -10.965 | -11.162 | 8.757 | 10.53 | 0 | 0.594 | 0.4 | 0.3 | 0.3 | 0.3 |
| Operating Expenses
| 1,119.264 | 1,341.048 | 2,832.866 | 892.317 | 148.259 | 208.206 | 202.886 | 284.466 | 193.486 | 99.363 | 65.127 | 37.049 | 29.264 | 38.837 | 37.708 | 35.424 | 31.563 | 22.817 | 10.768 | 29.234 | 25.782 | 33.004 | 29.269 | 15.811 | 6.2 | 6.2 | 5.6 | 5.9 |
| Operating Income
| -415.027 | -644.736 | -1,686.576 | -416.719 | -120.581 | -173.918 | -171.71 | -269.113 | -157.236 | -83.691 | -52.434 | -29.665 | -21.579 | -38.494 | -37.383 | -34.36 | -30.271 | -24.607 | -9.171 | -24.464 | -16.054 | -21.558 | -9.255 | -12.742 | -4.6 | -5.2 | -4.8 | -5.5 |
| Operating Income Ratio
| -0.422 | -0.403 | -1.471 | -0.876 | -6.461 | -5.072 | -5.508 | -17.528 | -4.338 | -2.73 | -2.507 | -1.344 | -1.469 | -112.227 | -115.025 | -32.293 | -20.007 | -5.255 | -1.241 | -2.962 | -1.362 | -1.437 | -0.385 | -5.148 | -3.833 | -7.429 | -9.6 | -55 |
| Total Other Income Expenses Net
| -128.004 | -8.911 | -27.96 | -1.54 | -12.113 | 0.108 | 0.067 | -0.031 | -0.12 | 0.615 | 0.449 | 1.025 | 2.5 | 0.485 | -0.49 | -1.238 | -6.175 | 1.539 | 10.965 | 11.232 | -1.219 | -1.139 | -0.49 | 0 | 0 | 0.3 | 0.2 | 0.1 |
| Income Before Tax
| -543.031 | -653.647 | -1,714.536 | -418.259 | -132.694 | -184.748 | -183.769 | -279.966 | -156.937 | -82.947 | -51.958 | -28.507 | -18.952 | -36.158 | -38.374 | -36.049 | -34.765 | -23.068 | -11.174 | -25.92 | -17.273 | -22.697 | -9.745 | 0 | 0 | -4.9 | -4.6 | -5.4 |
| Income Before Tax Ratio
| -0.552 | -0.409 | -1.496 | -0.879 | -7.11 | -5.388 | -5.895 | -18.235 | -4.329 | -2.705 | -2.484 | -1.291 | -1.29 | -105.417 | -118.074 | -33.881 | -22.978 | -4.926 | -1.512 | -3.138 | -1.466 | -1.513 | -0.405 | 0 | 0 | -7 | -9.2 | -54 |
| Income Tax Expense
| 2.031 | 4.292 | 29.215 | 9.246 | -2.592 | 1.358 | 2.309 | 2.317 | -6.402 | -5.168 | 0.025 | 0.077 | 0.412 | -0.45 | -0.203 | 1.689 | -0.675 | 0 | 2.003 | 1.456 | 0 | 0 | 0 | -0.551 | -0.1 | -0.4 | -0.3 | 0.1 |
| Net Income
| -545.062 | -657.939 | -1,743.751 | -427.505 | -130.102 | -184.748 | -183.769 | -279.966 | -156.937 | -82.947 | -51.983 | -28.507 | -19.364 | -35.708 | -38.374 | -36.049 | -34.765 | -23.068 | -11.174 | -25.92 | -17.273 | -22.697 | -9.745 | -12.191 | -4.5 | -4.8 | -4.5 | -5.5 |
| Net Income Ratio
| -0.554 | -0.411 | -1.521 | -0.899 | -6.971 | -5.388 | -5.895 | -18.235 | -4.329 | -2.705 | -2.485 | -1.291 | -1.318 | -104.105 | -118.074 | -33.881 | -22.978 | -4.926 | -1.512 | -3.138 | -1.466 | -1.513 | -0.405 | -4.926 | -3.75 | -6.857 | -9 | -55 |
| EPS
| -5.41 | -8.42 | -23.44 | -7.43 | -5.4 | -9.99 | -12.56 | -20.68 | -11.97 | -7.35 | -6.13 | -4.33 | -3.41 | -6.82 | -8.97 | -10.58 | -11.38 | -7.86 | -5.23 | -14.04 | -11.57 | -18.58 | -8.6 | -12.82 | -6.2 | -7.72 | -7.71 | -10.86 |
| EPS Diluted
| -5.41 | -8.42 | -23.44 | -7.43 | -5.4 | -9.99 | -12.56 | -20.68 | -11.97 | -7.35 | -6.13 | -4.33 | -3.41 | -6.82 | -8.97 | -10.58 | -11.38 | -7.86 | -5.23 | -14.04 | -11.57 | -18.58 | -8.6 | -12.82 | -6.2 | -7.72 | -7.71 | -10.86 |
| EBITDA
| -373.802 | -633.767 | -1,686.576 | -416.719 | -138.613 | -173.918 | -171.71 | -269.113 | -157.236 | -84.306 | -49.474 | -27.789 | -19.83 | -35.262 | -36.893 | -32.229 | -30.271 | -21.892 | -16.661 | -32.643 | -14.868 | -20.42 | -5.766 | -12.148 | -4.2 | -5.2 | -4.7 | -5.3 |
| EBITDA Ratio
| -0.38 | -0.396 | -1.471 | -0.876 | -7.428 | -5.072 | -5.508 | -17.528 | -4.338 | -2.75 | -2.365 | -1.259 | -1.35 | -102.805 | -113.517 | -30.29 | -20.007 | -4.675 | -2.255 | -3.952 | -1.262 | -1.361 | -0.24 | -4.908 | -3.5 | -7.429 | -9.4 | -53 |